CI
GBT

Cowen Inc’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Cowen Inc’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$3.54M Sell
67,300
-700
-1% -$40.2K 0.26% 67
2019
Q1 		$3.6M Sell
68,000
-10,000
-13% -$491K 0.39% 51
2018
Q4 		$3.2M Buy
78,000
+53,000
+212% +$1.99M 0.35% 63
2018
Q3 		$950K Hold
25,000
– – 0.09% 149
2018
Q2 		$1.13K Buy
+25,000
New +$1.14M 0.05% 200

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cowen Inc's GBT Position: Q2 2019 in Review

Cowen Inc reduced its Global Blood Therapeutics, Inc. (GBT) stake by 1% in Q2 2019, selling an estimated $40.2K and leaving 67,300 shares worth $3.54M. The position accounts for 0.26% of the portfolio, ranked #67.

Cowen Inc first reported a position in GBT in Q2 2018 and has held it in 5 quarters since. The position peaked at $3.6M in Q1 2019. 223 funds tracked by Wall St. Rank hold GBT as of Q2 2019.

  • Cowen Inc held 67,300 shares of Global Blood Therapeutics, Inc. worth $3.54M as of Q2 2019.
  • Cowen Inc sold 700 Global Blood Therapeutics, Inc. shares in Q2 2019, an estimated $40.2K.
  • Global Blood Therapeutics, Inc. made up 0.26% of Cowen Inc's portfolio in Q2 2019, its #67 holding.
  • Cowen Inc first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and has held it in 5 quarters since.
  • Cowen Inc's Global Blood Therapeutics, Inc. position peaked at $3.6M in Q1 2019.
  • 223 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.